Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 129 entries
Sorted by: Best Match Show Resources per page
[Education--courses nearby].

Sygeplejersken

Bergqvist LP.
PMID: 1448761
Sygeplejersken. 1992 May 13;92(20):28-9.

No abstract available.

Cite
Bergqvist LP. Uddannelse--kurser taet på. [Education--courses nearby]. Sygeplejersken. 1992;92(20):28-9
Bergqvist, L. P. (1992). Uddannelse--kurser taet på. [Education--courses nearby]. Sygeplejersken, 92(20), 28-9.
Bergqvist, L P. "Uddannelse--kurser taet på." [Education--courses nearby]. Sygeplejersken vol. 92,20 (1992): 28-9.
Bergqvist LP. Uddannelse--kurser taet på. [Education--courses nearby]. Sygeplejersken. 1992 May 13;92(20):28-9. Danish. PMID: 1448761.
Copy Download .nbib Format: NLM
[Work environment--a common task].

Sygeplejersken

Bergqvist LP, Nørgaard J.
PMID: 1471054
Sygeplejersken. 1992 Jul 22;92(30):18-20.

No abstract available.

Cite
Bergqvist LP, Nørgaard J. Arbejdsmiljø--en faelles opgave. [Work environment--a common task]. Sygeplejersken. 1992;92(30):18-20
Bergqvist, L. P., & Nørgaard, J. (1992). Arbejdsmiljø--en faelles opgave. [Work environment--a common task]. Sygeplejersken, 92(30), 18-20.
Bergqvist, L P, and Nørgaard, J. "Arbejdsmiljø--en faelles opgave." [Work environment--a common task]. Sygeplejersken vol. 92,30 (1992): 18-20.
Bergqvist LP, Nørgaard J. Arbejdsmiljø--en faelles opgave. [Work environment--a common task]. Sygeplejersken. 1992 Jul 22;92(30):18-20. Danish. PMID: 1471054.
Copy Download .nbib Format: NLM
Incidence trends in high-grade primary brain tumors in males and females.

Oncology letters

Nilsson J, Holgersson G, Carlsson T, Henriksson R, Bergström S, Bergqvist M.
PMID: 28454474
Oncol Lett. 2017 Apr;13(4):2831-2837. doi: 10.3892/ol.2017.5770. Epub 2017 Feb 23.

The focus of the present review is to investigate whether there is a variation in the incidence rates between male and female patients with high-grade primary brain tumors and if there are altered incidence rates associated with the time...

Cite
Nilsson J, Holgersson G, Carlsson T, et al. Incidence trends in high-grade primary brain tumors in males and females. Oncol Lett. 2017;13(4):2831-2837doi: 10.3892/ol.2017.5770.
Nilsson, J., Holgersson, G., Carlsson, T., Henriksson, R., Bergström, S., & Bergqvist, M. (2017). Incidence trends in high-grade primary brain tumors in males and females. Oncology letters, 13(4), 2831-2837. https://doi.org/10.3892/ol.2017.5770
Nilsson, Jonas, et al. "Incidence trends in high-grade primary brain tumors in males and females." Oncology letters vol. 13,4 (2017): 2831-2837. doi: https://doi.org/10.3892/ol.2017.5770
Nilsson J, Holgersson G, Carlsson T, Henriksson R, Bergström S, Bergqvist M. Incidence trends in high-grade primary brain tumors in males and females. Oncol Lett. 2017 Apr;13(4):2831-2837. doi: 10.3892/ol.2017.5770. Epub 2017 Feb 23. PMID: 28454474; PMCID: PMC5403298.
Copy Download .nbib Format: NLM
The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial.

Asian Pacific journal of cancer prevention : APJCP

Holgersson G, Bergqvist M, Nilsson J, Thureson M, Harmenberg J, Bergstrom S.
PMID: 28669167
Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1555-1560. doi: 10.22034/APJCP.2017.18.6.1555.

Background: The aim of the present study was to investigate any prognostic value of pre-treatment anemia, leukocytosis and thrombocytosis in patients with advanced pretreated NSCLC. Methods: A randomized, multicenter phase II study comparing the IGF-1R modulator AXL with standard...

Cite
Holgersson G, Bergqvist M, Nilsson J, et al. The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial. Asian Pac J Cancer Prev. 2017;18(6):1555-1560doi: 10.22034/APJCP.2017.18.6.1555.
Holgersson, G., Bergqvist, M., Nilsson, J., Thureson, M., Harmenberg, J., & Bergstrom, S. (2017). The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial. Asian Pacific journal of cancer prevention : APJCP, 18(6), 1555-1560. https://doi.org/10.22034/APJCP.2017.18.6.1555
Holgersson, Georg, et al. "The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial." Asian Pacific journal of cancer prevention : APJCP vol. 18,6 (2017): 1555-1560. doi: https://doi.org/10.22034/APJCP.2017.18.6.1555
Holgersson G, Bergqvist M, Nilsson J, Thureson M, Harmenberg J, Bergstrom S. The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial. Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1555-1560. doi: 10.22034/APJCP.2017.18.6.1555. PMID: 28669167; PMCID: PMC6373797.
Copy Download .nbib Format: NLM
Solid-binding peptides for immobilisation of thermostable enzymes to hydrolyse biomass polysaccharides.

Biotechnology for biofuels

Care A, Petroll K, Gibson ESY, Bergquist PL, Sunna A.
PMID: 28184244
Biotechnol Biofuels. 2017 Feb 02;10:29. doi: 10.1186/s13068-017-0715-2. eCollection 2017.

BACKGROUND: Solid-binding peptides (SBPs) bind strongly to a diverse range of solid materials without the need for any chemical reactions. They have been used mainly for the functionalisation of nanomaterials but little is known about their use for the...

Cite
Care A, Petroll K, Gibson ESY, et al. Solid-binding peptides for immobilisation of thermostable enzymes to hydrolyse biomass polysaccharides. Biotechnol Biofuels. 2017;10:29doi: 10.1186/s13068-017-0715-2.
Care, A., Petroll, K., Gibson, E. S. Y., Bergquist, P. L., & Sunna, A. (2017). Solid-binding peptides for immobilisation of thermostable enzymes to hydrolyse biomass polysaccharides. Biotechnology for biofuels, 1029. https://doi.org/10.1186/s13068-017-0715-2
Care, Andrew, et al. "Solid-binding peptides for immobilisation of thermostable enzymes to hydrolyse biomass polysaccharides." Biotechnology for biofuels vol. 10 (2017): 29. doi: https://doi.org/10.1186/s13068-017-0715-2
Care A, Petroll K, Gibson ESY, Bergquist PL, Sunna A. Solid-binding peptides for immobilisation of thermostable enzymes to hydrolyse biomass polysaccharides. Biotechnol Biofuels. 2017 Feb 02;10:29. doi: 10.1186/s13068-017-0715-2. eCollection 2017. PMID: 28184244; PMCID: PMC5289021.
Copy Download .nbib Format: NLM
Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review.

World journal of oncology

Nilsson J, Holgersson G, Carlsson T, Henriksson R, Bergstrom S, Bergqvist M.
PMID: 28983366
World J Oncol. 2016 Aug;7(4):59-69. doi: 10.14740/wjon976w. Epub 2016 Sep 03.

BACKGROUND: Incidence rates of adult low-grade primary brain tumors have previously been widely analyzed nationwide across the world, and most of these studies include data on incidence rates in men and women separately. However, to our knowledge, no worldwide...

Cite
Nilsson J, Holgersson G, Carlsson T, et al. Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review. World J Oncol. 2016;7(4):59-69doi: 10.14740/wjon976w.
Nilsson, J., Holgersson, G., Carlsson, T., Henriksson, R., Bergstrom, S., & Bergqvist, M. (2016). Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review. World journal of oncology, 7(4), 59-69. https://doi.org/10.14740/wjon976w
Nilsson, Jonas, et al. "Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review." World journal of oncology vol. 7,4 (2016): 59-69. doi: https://doi.org/10.14740/wjon976w
Nilsson J, Holgersson G, Carlsson T, Henriksson R, Bergstrom S, Bergqvist M. Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review. World J Oncol. 2016 Aug;7(4):59-69. doi: 10.14740/wjon976w. Epub 2016 Sep 03. PMID: 28983366; PMCID: PMC5624701.
Copy Download .nbib Format: NLM
Generic realignment in primuloid families of the Ericales s.l.: a phylogenetic analysis based on DNA sequences from three chloroplast genes and morphology.

American journal of botany

Källersjö M, Bergqvist G, Anderberg AA.
PMID: 10991903
Am J Bot. 2000 Sep;87(9):1325-41.

The phylogenetic interrelationships in Primulaceae, Myrsinaceae, and Theophrastaceae were investigated using DNA sequence data from the chloroplast genes atpB, ndhF, and rbcL. The three genes were analyzed separately, together, and in combination with morphology, using parsimony jackknifing. The sequence...

Cite
Källersjö M, Bergqvist G, Anderberg AA. Generic realignment in primuloid families of the Ericales s.l.: a phylogenetic analysis based on DNA sequences from three chloroplast genes and morphology. Am J Bot. 2000;87(9):1325-41
Källersjö, M., Bergqvist, G., & Anderberg, A. A. (2000). Generic realignment in primuloid families of the Ericales s.l.: a phylogenetic analysis based on DNA sequences from three chloroplast genes and morphology. American journal of botany, 87(9), 1325-41.
Källersjö, M, et al. "Generic realignment in primuloid families of the Ericales s.l.: a phylogenetic analysis based on DNA sequences from three chloroplast genes and morphology." American journal of botany vol. 87,9 (2000): 1325-41.
Källersjö M, Bergqvist G, Anderberg AA. Generic realignment in primuloid families of the Ericales s.l.: a phylogenetic analysis based on DNA sequences from three chloroplast genes and morphology. Am J Bot. 2000 Sep;87(9):1325-41. PMID: 10991903.
Copy Download .nbib Format: NLM
Defect-induced magnetic structure in (Ga(1)-(x)Mn(x))As.

Physical review letters

Korzhavyi PA, Abrikosov IA, Smirnova EA, Bergqvist L, Mohn P, Mathieu R, Svedlindh P, Sadowski J, Isaev EI, Vekilov YKh, Eriksson O.
PMID: 12005716
Phys Rev Lett. 2002 May 06;88(18):187202. doi: 10.1103/PhysRevLett.88.187202. Epub 2002 Apr 18.

We show that magnetic structures involving partial disorder of local magnetic moments on the Mn atoms in (Ga(1)-(x)Mn(x))As lower the total energy, compared to the case of perfect ferromagnetic ordering, when As defects on the Ga sublattice are present....

Cite
Korzhavyi PA, Abrikosov IA, Smirnova EA, et al. Defect-induced magnetic structure in (Ga(1)-(x)Mn(x))As. Phys Rev Lett. 2002;88(18):187202doi: 10.1103/PhysRevLett.88.187202.
Korzhavyi, P. A., Abrikosov, I. A., Smirnova, E. A., Bergqvist, L., Mohn, P., Mathieu, R., Svedlindh, P., Sadowski, J., Isaev, E. I., Vekilov, Y. K. h., & Eriksson, O. (2002). Defect-induced magnetic structure in (Ga(1)-(x)Mn(x))As. Physical review letters, 88(18), 187202. https://doi.org/10.1103/PhysRevLett.88.187202
Korzhavyi, P A, et al. "Defect-induced magnetic structure in (Ga(1)-(x)Mn(x))As." Physical review letters vol. 88,18 (2002): 187202. doi: https://doi.org/10.1103/PhysRevLett.88.187202
Korzhavyi PA, Abrikosov IA, Smirnova EA, Bergqvist L, Mohn P, Mathieu R, Svedlindh P, Sadowski J, Isaev EI, Vekilov YKh, Eriksson O. Defect-induced magnetic structure in (Ga(1)-(x)Mn(x))As. Phys Rev Lett. 2002 May 06;88(18):187202. doi: 10.1103/PhysRevLett.88.187202. Epub 2002 Apr 18. PMID: 12005716.
Copy Download .nbib Format: NLM
Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery.

Clinical drug investigation

Bergqvist D, Solhaug JH, Holmdahl L, Eriksson UG, Andersson M, Boberg B, Ogren M.
PMID: 17516699
Clin Drug Investig. 2004;24(3):127-36. doi: 10.2165/00044011-200424030-00001.

OBJECTIVE: The oral direct thrombin inhibitor (oral DTI) ximelagatran and its active form, melagatran, which can be administered subcutaneously, were investigated for the prevention and treatment of thromboembolic complications.DESIGN AND PATIENTS: In this randomised, double-blind, double-dummy, parallel-group study in...

Cite
Bergqvist D, Solhaug JH, Holmdahl L, et al. Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery. Clin Drug Investig. 2004;24(3):127-36doi: 10.2165/00044011-200424030-00001.
Bergqvist, D., Solhaug, J. H., Holmdahl, L., Eriksson, U. G., Andersson, M., Boberg, B., & Ogren, M. (2004). Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery. Clinical drug investigation, 24(3), 127-36. https://doi.org/10.2165/00044011-200424030-00001
Bergqvist, David, et al. "Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery." Clinical drug investigation vol. 24,3 (2004): 127-36. doi: https://doi.org/10.2165/00044011-200424030-00001
Bergqvist D, Solhaug JH, Holmdahl L, Eriksson UG, Andersson M, Boberg B, Ogren M. Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery. Clin Drug Investig. 2004;24(3):127-36. doi: 10.2165/00044011-200424030-00001. PMID: 17516699.
Copy Download .nbib Format: NLM
Conditions for noncollinear instabilities of ferromagnetic materials.

Physical review letters

Lizárraga R, Nordström L, Bergqvist L, Bergman A, Sjöstedt E, Mohn P, Eriksson O.
PMID: 15447446
Phys Rev Lett. 2004 Sep 03;93(10):107205. doi: 10.1103/PhysRevLett.93.107205. Epub 2004 Sep 03.

Two criteria have been identified here which determine whether a magnetic metal orders in a collinear (e.g., ferromagnet) or noncollinear (e.g., spin-spiral) arrangement. These criteria involve the ratio between the strength of the exchange interaction and the width of...

Cite
Lizárraga R, Nordström L, Bergqvist L, et al. Conditions for noncollinear instabilities of ferromagnetic materials. Phys Rev Lett. 2004;93(10):107205doi: 10.1103/PhysRevLett.93.107205.
Lizárraga, R., Nordström, L., Bergqvist, L., Bergman, A., Sjöstedt, E., Mohn, P., & Eriksson, O. (2004). Conditions for noncollinear instabilities of ferromagnetic materials. Physical review letters, 93(10), 107205. https://doi.org/10.1103/PhysRevLett.93.107205
Lizárraga, Raquel, et al. "Conditions for noncollinear instabilities of ferromagnetic materials." Physical review letters vol. 93,10 (2004): 107205. doi: https://doi.org/10.1103/PhysRevLett.93.107205
Lizárraga R, Nordström L, Bergqvist L, Bergman A, Sjöstedt E, Mohn P, Eriksson O. Conditions for noncollinear instabilities of ferromagnetic materials. Phys Rev Lett. 2004 Sep 03;93(10):107205. doi: 10.1103/PhysRevLett.93.107205. Epub 2004 Sep 03. PMID: 15447446.
Copy Download .nbib Format: NLM
Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden.

The European journal of health economics : HEPAC : health economics in prevention and care

Lundkvist J, Bergqvist D, Jönsson B.
PMID: 15609193
Eur J Health Econ. 2003 Nov;4(4):254-62. doi: 10.1007/s10198-003-0175-4.

Deep-vein thrombosis and pulmonary embolism are important causes of morbidity and mortality among patients undergoing major surgery. Fondaparinux is a new antithrombotic agent for use in prophylaxis, and this study compared its cost and effect vs. enoxaparin as prophylactic...

Cite
Lundkvist J, Bergqvist D, Jönsson B. Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden. Eur J Health Econ. 2003;4(4):254-62doi: 10.1007/s10198-003-0175-4.
Lundkvist, J., Bergqvist, D., & Jönsson, B. (2003). Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden. The European journal of health economics : HEPAC : health economics in prevention and care, 4(4), 254-62. https://doi.org/10.1007/s10198-003-0175-4
Lundkvist, Jonas, et al. "Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden." The European journal of health economics : HEPAC : health economics in prevention and care vol. 4,4 (2003): 254-62. doi: https://doi.org/10.1007/s10198-003-0175-4
Lundkvist J, Bergqvist D, Jönsson B. Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden. Eur J Health Econ. 2003 Nov;4(4):254-62. doi: 10.1007/s10198-003-0175-4. PMID: 15609193.
Copy Download .nbib Format: NLM
CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression.

Journal of translational medicine

Schüle JM, Bergkvist L, Håkansson L, Gustafsson B, Håkansson A.
PMID: 15613231
J Transl Med. 2004 Dec 21;2(1):45. doi: 10.1186/1479-5876-2-45.

BACKGROUND: Immunosuppression is documented in several malignant diseases, including breast cancer. Subsequently, future therapeutic concepts might include immunological approaches. However, detailed knowledge about tumor immunogenicity and host immunoreactivity, and how to assess these adequately, is still limited. We studied...

Cite
Schüle JM, Bergkvist L, Håkansson L, et al. CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression. J Transl Med. 2004;2(1):45doi: 10.1186/1479-5876-2-45.
Schüle, J. M., Bergkvist, L., Håkansson, L., Gustafsson, B., & Håkansson, A. (2004). CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression. Journal of translational medicine, 2(1), 45. https://doi.org/10.1186/1479-5876-2-45
Schüle, Jana M, et al. "CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression." Journal of translational medicine vol. 2,1 (2004): 45. doi: https://doi.org/10.1186/1479-5876-2-45
Schüle JM, Bergkvist L, Håkansson L, Gustafsson B, Håkansson A. CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression. J Transl Med. 2004 Dec 21;2(1):45. doi: 10.1186/1479-5876-2-45. PMID: 15613231; PMCID: PMC545070.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 129 entries